Literature DB >> 8452580

Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus.

K S Barron1, E D Silverman, J Gonzales, J D Reveille.   

Abstract

OBJECTIVE: To determine the frequency of systemic lupus erythematosus (SLE)-associated clinical manifestations, autoantibodies, and HLA class II alleles in a large cohort of patients with childhood-onset SLE.
METHODS: Eighty children with SLE onset before age 18 (27 before age 11) were studied for the frequency of renal, neuropsychiatric, and hematologic complications as well as for anti-native DNA, Ro, La, Sm, and U1 RNP autoantibodies. HLA-DR, DQ, and DP alleles were determined by oligotyping. The results were compared with findings in 213 adults with SLE onset at or after age 18 years.
RESULTS: Renal involvement was more frequent in those with childhood-onset SLE, especially those with onset before age 11 (82%, compared with 53% in adults). Anti-U1 RNP was more common in American blacks with SLE onset before age 18. HLA-DRB1*0301, DQA1*0501, DQB1*0201 was more common in Caucasians and DRB1*1503, DRB5*0101, DQA1*0102, DQB1*0602 in American blacks, regardless of age at SLE onset. Anti-Sm autoantibodies were most highly associated with HLA-DQA1*0102 and DQB1*0602.
CONCLUSION: While childhood-onset SLE shares many immunogenetic and serologic similarities to adult-onset disease, important clinical differences nevertheless exist in children with this disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452580     DOI: 10.1002/art.1780360310

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

Review 1.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  Population-level evidence for an autoimmune etiology of epilepsy.

Authors:  Mei-Sing Ong; Isaac S Kohane; Tianxi Cai; Mark P Gorman; Kenneth D Mandl
Journal:  JAMA Neurol       Date:  2014-05       Impact factor: 18.302

3.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 4.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

5.  Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.

Authors:  Cécile Picard; Jean-Christophe Lega; Bruno Ranchin; Pierre Cochat; Natalia Cabrera; Nicole Fabien; Alexandre Belot
Journal:  Pediatr Nephrol       Date:  2017-03-25       Impact factor: 3.714

6.  Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort.

Authors:  Deborah M Levy; Christine A Peschken; Lori B Tucker; Gaëlle Chédeville; Adam M Huber; Janet E Pope; Earl D Silverman
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

7.  End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.

Authors:  Linda T Hiraki; Bing Lu; Steven R Alexander; Tamara Shaykevich; Graciela S Alarcón; Daniel H Solomon; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2011-07

8.  Predictors of kidney disease in a cohort of pediatric patients with lupus.

Authors:  S D Sule; D G Moodalbail; J Burnham; B Fivush; S L Furth
Journal:  Lupus       Date:  2015-02-12       Impact factor: 2.911

9.  Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.

Authors:  Linda T Hiraki; Candace H Feldman; Jun Liu; Graciela S Alarcón; Michael A Fischer; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2012-08

10.  Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.

Authors:  Mohamed O Olfat; Sulaiman M Al-Mayouf; Mohamed A Muzaffer
Journal:  Clin Rheumatol       Date:  2004-07-23       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.